Skip to Main Content

Cellular therapies are on the cusp of approval in the blood cancer space — but there’s work yet to be done in reengineering T cells to target solid tumor cancers.

Dr. Kristin Anderson of Fred Hutchinson Cancer Center has some intriguing preclinical work in developing T cells that know how to kill ovarian and pancreatic cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!